- 7-spiroindanyloxymorphone Spiroindanyloxymorphone SIOM 7-(2'-spiroindanyl)oxymorphone BDBM50297170 7-(Spiroindano)Oxymorphone CHEMBL399708
- 7-spiroindanyloxymorphone SIOM BDBM50045216 7-(Spiroindano)Oxymorphone
- CHEMBL298314 7-(4'-Methoxy-2'-spiroindanyl)oxymorphone BDBM50058149
- BDBM50058153 CHEMBL297470 7-(5',6'-Benzo-2'-spiroindanyl)oxymorphone
- Oxycet Roxiprin Numorphan 10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(oxymorphone) 10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(xymorphone) Tylox-325 PERCODAN-DEMI Tylox CHEMBL963 Percodan BDBM50001707 Percocet Roxicet Roxilox OXYMORPHONE 10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one Codoxy Combunox 10,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-trien-14-one Opana
- Ohkawa, S; DiGiacomo, B; Larson, DL; Takemori, AE; Portoghese, PS 7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors. J Med Chem 40: 1720-5 (1997)
- Fang, X; Larson, DL; Portoghese, PS 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands. J Med Chem 40: 3064-70 (1997)
- Loew, GH; Berkowitz, DS Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics. J Med Chem 21: 101-6 (1978)
- Koolpe, GA; Nelson, WL; Gioannini, TL; Angel, L; Appelmans, N; Simon, EJ Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone. J Med Chem 28: 949-57 (1985)
- Metzger, TG; Paterlini, MG; Ferguson, DM; Portoghese, PS Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the"address" recognition locus. J Med Chem 44: 857-62 (2001)
- Portoghese, PS; Moe, ST; Takemori, AE A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists. J Med Chem 36: 2572-4 (1993)
- Ananthan, S; Khare, NK; Saini, SK; Seitz, LE; Bartlett, JL; Davis, P; Dersch, CM; Porreca, F; Rothman, RB; Bilsky, EJ Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]. J Med Chem 47: 1400-12 (2004)
- Klein, P; Nelson, WL O3-(2-carbomethoxyallyl) ethers of opioid ligands derived from oxymorphone, naltrexone, etorphine, diprenorphine, norbinaltorphimine, and naltrindole. Unexpected O3-dealkylation in the opioid radioligand displacement assay. J Med Chem 35: 4589-94 (1993)
- Koolpe, GA; Nelson, WL; Gioannini, TL; Angel, L; Simon, EJ Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand. J Med Chem 27: 1718-23 (1984)